🇺🇸 FDA
Pipeline program

Ketamine (Ketalar) Dose Level 1

STUDY22100018

Phase 1 small_molecule completed

Quick answer

Ketamine (Ketalar) Dose Level 1 for Pain, Postoperative is a Phase 1 program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Grace Therapeutics
Indication
Pain, Postoperative
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials